ArticleLa Radiologia medica2026
Dual-task deep learning model for prediction of medulloblastoma molecular subgroups with preoperative brain MRI.
Article in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neurosurgical Application of Artificial Intelligence in Pediatric Neuro-Oncology.Journal of Korean Neurosurgical Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeTo develop a deep learning model for predicting molecular subgroups of medulloblastoma (MB) using preoperative brain MRI. MATERIALS AND
methodsThis study included a cohort of 350 patients with MB for model development. Preoperative multiparametric brain MRIs were acquired, and molecular classification data for tumor samples were analyzed. A dual-task deep learning model, composed of a 3D Swin Transformer backbone and a Transformer-based mask decoder, was developed for the prediction of MB molecular subgroups. The model was jointly optimized with a parallel task of tumor and cerebellum segmentation. Ablation analysis was conducted to verify the effectiveness of the dual-task model design. An independent test cohort of 126 patients with MB was established to validate the predictive performance of the dual-task model.
resultsOur dual-task deep learning model demonstrated superior performance for MB molecular subgroup prediction, achieving an AUC of 0.877, accuracy of 88.9%, sensitivity of 71.6%, and specificity of 91.9%. The performance remained robust across both adult and pediatric age populations, with AUCs of 0.915 and 0.871, respectively. Furthermore, our approach exhibited effective generalization to the independent test cohort, yielding an AUC of 0.853, accuracy of 89.7%, sensitivity of 73.5%, and specificity of 92.1%. Ablation analysis demonstrated a significant improvement in AUC of 0.169 (95% CI 0.097-0.244) when using the dual-task model design. In comparison with the radiomics-based model, our deep learning model achieved a higher AUC by 0.156 (95% CI 0.079-0.233).
conclusionOur proposed dual-task deep learning model enables automated and accurate prediction of MB molecular subgroups.
Indexed as
Identifiers
41117885What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.